|
|
Volumn 7, Issue 5, 2001, Pages 275-276
|
|
Blockade of gamma interferon might be beneficial in MS
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA4 INTEGRIN ANTIBODY;
BETA INTERFERON;
CYTOKINE;
ETANERCEPT;
GAMMA INTERFERON;
GAMMA INTERFERON ANTIBODY;
GLATIRAMER;
IMMUNOGLOBULIN;
INTERLEUKIN 12;
LENERCEPT;
LIGAND;
OSTEOPONTIN;
PROTEIN ANTIBODY;
RECOMBINANT GAMMA INTERFERON;
RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
UNCLASSIFIED DRUG;
BLOOD BRAIN BARRIER;
CLINICAL TRIAL;
CYTOKINE PRODUCTION;
DEMYELINATING DISEASE;
DISEASE CLASSIFICATION;
DISEASE COURSE;
DISEASE EXACERBATION;
DRUG CONTRAINDICATION;
DRUG EFFECT;
DRUG PENETRATION;
DRUG USE;
HUMAN;
LYMPHOCYTE PROLIFERATION;
MULTIPLE SCLEROSIS;
NONHUMAN;
NOTE;
OUTCOMES RESEARCH;
PATHOGENESIS;
PHARMACOLOGICAL BLOCKING;
PHYSICAL DISABILITY;
RELAPSE;
RHEUMATOID ARTHRITIS;
T LYMPHOCYTE;
TH1 CELL;
TH2 CELL;
TREATMENT FAILURE;
ANTIBODIES;
HUMANS;
INTERFERON TYPE II;
MULTIPLE SCLEROSIS;
|
|
EID: 0034748269
PISSN: 13524585
EISSN: None
Source Type: Journal
DOI: 10.1191/135245801681137951 Document Type: Note |
|
Times cited : (16)
|
|
References (6)
|
